Feasibility of performance of drug-eluting bead transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma (HCC) as an outpatient procedure using 70-150 μm microspheres
Feasibility of performance of drug-eluting bead transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma (HCC) as an outpatient procedure using 70-150 μm microspheres
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started